CDK4/6 inhibition versus mTOR blockade as second-line strategy in postmenopausal patients with hormone receptor-positive advanced breast cancer: A network meta-analysis.

Autor: Huang, Hong-Wei, Huang, Li-Sheng, Xu, Qi-Ni, Wang, Hong-Biao, Li, Xu-Yuan, Lin, Jia-Zhou, Bush., Eric
Zdroj: Medicine; Jan2019, Vol. 98 Issue 1, pe13909-e13909, 1p
Databáze: Complementary Index